Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist
- 1 July 1984
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 149 (5) , 496-500
- https://doi.org/10.1016/0002-9378(84)90023-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- KETANSERIN: A SELECTIVE ANTAGONIST OF 5-HT2 SEROTONINERGIC RECEPTORSThe Lancet, 1983
- MECHANISM OF ACTION OF KETANSERINThe Lancet, 1982
- Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468)European Journal of Pharmacology, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- ABNORMAL PLATELET FUNCTION IN PRE‐ECLAMPSIABJOG: An International Journal of Obstetrics and Gynaecology, 1978
- THE INTERACTION OF SEROTONIN AND NORADRENALINE ON THE PERFUSED ARTERYBritish Journal of Pharmacology and Chemotherapy, 1966
- SEROTONIN-INDUCED ACUTE NEPHROSIS AND RENAL CORTICAL NECROSIS IN RATS - A MORPHOLOGIC STUDY WITH PREGNANCY CORRELATIONS1960